01.13.21

EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 Vaccine

Source: FirstWord

01.07.21

Moderna’s COVID-19 Vaccine Becomes Second to Nab EU Authorization

Source: FirstWord

11.03.20

GenSight Biologics Reports Validation of Lumevoq Marketing Authorization Application (MAA) by European Medicines Agency

Source: GenSight Biologics

10.06.20

Samsung Bioepis and Biogen Announce EMA Filing Acceptance of Proposed Lucentis Biosimilar

Source: Samsung Bioepis

10.02.20

EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222

Source: FirstWord

06.29.20

Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe

Source: Eyewire News

04.06.20

EU Body Backs Compassionate Use of Gilead’s Remdesivir for COVID-19

Source: FirstWord

03.02.20

EMA Grants Two Product Designations to Janssen’s RPGR Gene Therapy for X-Linked Retinitis Pigmentosa

Source: Janssen

01.02.20

Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in Europe

Source: Aerie Pharmaceuticals

12.16.19

Novartis Receives Positive CHMP Opinion for Beovu (Brolucizumab) for the Treatment of Wet AMD

Source: Novartis

View more stories